Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis

A Waldthaler; C Schramm; A Bergquist

doi:10.1016/j.ejmg.2021.104231

Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis

Standard

Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. / Waldthaler, A; Schramm, C; Bergquist, A.

In: EUR J MED GENET, Vol. 64, No. 6, 06.2021, p. 104231.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Waldthaler, A, Schramm, C & Bergquist, A 2021, 'Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis', EUR J MED GENET, vol. 64, no. 6, pp. 104231. https://doi.org/10.1016/j.ejmg.2021.104231

APA

Waldthaler, A., Schramm, C., & Bergquist, A. (2021). Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. EUR J MED GENET, 64(6), 104231. https://doi.org/10.1016/j.ejmg.2021.104231

Vancouver

Waldthaler A, Schramm C, Bergquist A. Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. EUR J MED GENET. 2021 Jun;64(6):104231. https://doi.org/10.1016/j.ejmg.2021.104231

Bibtex

@article{557cf3c1520247faae91e98ab0416609,

title = "Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis",

abstract = "Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.",

author = "A Waldthaler and C Schramm and A Bergquist",

note = "Copyright {\textcopyright} 2021. Published by Elsevier Masson SAS.",

year = "2021",

month = jun,

doi = "10.1016/j.ejmg.2021.104231",

language = "English",

volume = "64",

pages = "104231",

journal = "EUR J MED GENET",

issn = "1769-7212",

publisher = "Elsevier Masson SAS",

number = "6",

}

RIS

TY - JOUR

T1 - Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis

AU - Waldthaler, A

AU - Schramm, C

AU - Bergquist, A

PY - 2021/6

Y1 - 2021/6

N2 - Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.

AB - Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.

U2 - 10.1016/j.ejmg.2021.104231

DO - 10.1016/j.ejmg.2021.104231

M3 - SCORING: Review article

C2 - 33905896

VL - 64

SP - 104231

JO - EUR J MED GENET

JF - EUR J MED GENET

SN - 1769-7212

IS - 6

ER -